<DOC>
	<DOC>NCT01017263</DOC>
	<brief_summary>The purpose of this study to assess the effects of chronic administration of Vyvanse (lis-dexamphetamine) on glucose metabolism in a sample of children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) who also have glucose intolerance and are obese.</brief_summary>
	<brief_title>Vyvanse and Glucose Intolerance in Children With Attention Deficit Hyperactivity Disorder (ADHD) and Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<mesh_term>Dextroamphetamine</mesh_term>
	<criteria>male or female, ages between 8 and 17 Body Mass Index &gt; 30 fasting blood sugar between 90100 mg/dl 2 hour post prandial &gt;140 &lt;180 mg/dl meets criteria for a diagnosis of ADHD, any subtype known cardiovascular disease or diabetes structural cardiac abnormalities, abnormal ECGs, family history of sudden death positive urine drug screen fasting blood sugar level &gt; 126 mg/dl HbA1c &gt; 6.5 % Weight &gt; 300 lbs</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Glucose Intolerance</keyword>
	<keyword>Obesity</keyword>
	<keyword>Vyvanse</keyword>
</DOC>